Abstract

Summary form only given. To test the hypothesis that patients with advanced structural disease and congestive failure have intermediate heart rate variability (HRV) values, the authors compared HRV in 33 young healthy subjects without evidence of heart disease, 23 patients with ischemic heart disease complicated by stable NYHA class II-III heart failure (CHF), and 13 patients who died during Holter monitoring (sudden cardiac death-SCD). Five CHF patients died after 9+or-5 months (CHF/D). Two HRV measures, SDANN (standard deviation (SD) of the mean of sinus R-R intervals (R-R) for successive 5-minute periods over 24 h) and SD (mean of SD of R-R for successive 5-min periods over 24 h) were determined from 24-h Holter records. Group differences were tested by analysis of variance. The data suggest that there is a spectrum of HRV that is highest in normal young subjects, lowest in SCD patients, and intermediate in the CHF group. However, HRV values in all CHF/D patients approximated those for SCD patients, suggesting that progression of disease and increasing risk of dying are associated with a decline in HRV. HRV measures may thus provide a tool for monitoring mortality increase in patients with heart disease. >

Full Text

Published Version

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.